Latest Upcoming Webinars & Online Events

Join us for an exclusive Ask Me Anything (AMA) session with renowned chemist Andrew Wood as we delve into the fascinating world of psychedelics, focusing on the chemistry of psilocybin. This event will provide a unique opportunity to explore the scientific aspects of psilocybin, including its analytical approaches and mechanisms of action

The CLIA proficiency testing revisions will take effect on July 11, 2024, introducing significant changes to both microbiology and non-microbiology laboratory sections. These updates include modifications to grading, reporting and the regulation of certain analytes.
Join Dr. Bremansu Osa-Andrews from the University of Florida for an in-depth webinar where he will elucidate the details of the CLIA 2024 final rule, helping laboratories stay informed and prepared for future inspections.

Immune cell activation, differentiation and function are metabolically demanding processes, and it has now become clear that nutrient access and metabolism play a major role in regulating lymphocyte fate and function. These axes of regulation are crucially important in shaping the immune system when it is activating in metabolically demanding environments, such as tumor tissue. Indeed, the immune response to cancer is characterized by several metabolic defects. In this webinar, Dr. Delgoffe will discuss some of these metabolic insufficiencies within the T cell compartment of solid tumors and reveal novel insights into how these metabolic nodes may be modulated to improve the immune response to cancer.

Advances in monoclonal antibody (mAb) engineering have led to additional challenges in the purification of these modalities, including high levels of aggregates. Ion exchange chromatography is often not sufficient to achieve purity targets meaning hydrophobic interaction chromatography (HIC) and mixed-mode resins are needed as orthogonal tools. These technologies can be implemented in flow-through mode allowing for high loadings and fast processing times, making them well-suited for large-scale implementation.

This webinar highlights three case studies that illustrate how novel chromatographic tools can improve the purification process for complex therapeutics by reducing the levels of aggregates and host cell proteins (HCPs) and effectively clearing retroviruses.

The liver is a very good example of how tissue architecture can influence aging. Composed mainly of hepatocytes, the position of these cells is key to their role and determines changes in their metabolism and aging profile.

Researchers from the Max Planck Institute have conducted an in-depth multiomics analysis of functional and healthy hepatocytes, characterizing transcriptional, epigenetic, lipidomic and functional signatures to understand the effects of aging.

In this webinar, you’ll hear all about their research, including the novel perfusion technology for resected mouse liver that makes it easy and convenient to obtain viable hepatocytes to analyze.

This exclusive AMA offers a rare opportunity to engage directly with Dr. Thomas Webster, a world-renowned biomedical engineer and entrepreneur with over 28 years of experience at the forefront of nanotechnology. Dr. Webster is well known for his pioneering work in harnessing the power of nanomaterials to revolutionize healthcare applications.

In this webinar, our expert speaker will discuss the types of analytical testing that can be effectively employed in the early stages of therapeutic development and subsequently scaled to meet production challenges.

In this webinar, you’ll hear from two experts about their research into microbial communities and the impact of nanopore sequencing technologies on their work.

Explore the latest knowledge on the safety, authenticity and quality of food and beverages, as well as the technology that supports the critical work done to ensure the integrity of the food supply chain.

Pharmacogenomic testing uses a patient’s genome to identify their response to a drug, forming a key part of personalized medicine.
Hundreds of clinical pharmacogenomics (PGx) tests are currently available on the market in the United States. With so many tests available, how can you determine that a test is clinically and analytically valid and holds clinical utility?
In this webinar, our expert speaker will outline the ACCE Model Project Framework as a tool for evaluating pharmacogenomic tests, describing the key considerations to take into account when implementing these tests.
You’ll learn how to select the genetic variants to be tested, choose the appropriate genotyping technology and develop laboratory procedures for sample processing and data analysis.